A voxel-wise assessment of growth differences in infants developing autism spectrum disorder.


Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2021
Historique:
received: 22 09 2020
revised: 25 11 2020
accepted: 21 12 2020
pubmed: 10 1 2021
medline: 29 6 2021
entrez: 9 1 2021
Statut: ppublish

Résumé

Autism Spectrum Disorder (ASD) is a phenotypically and etiologically heterogeneous developmental disorder typically diagnosed around 4 years of age. The development of biomarkers to help in earlier, presymptomatic diagnosis could facilitate earlier identification and therefore earlier intervention and may lead to better outcomes, as well as providing information to help better understand the underlying mechanisms of ASD. In this study, magnetic resonance imaging (MRI) scans of infants at high familial risk, from the Infant Brain Imaging Study (IBIS), at 6, 12 and 24 months of age were included in a morphological analysis, fitting a mixed-effects model to Tensor Based Morphometry (TBM) results to obtain voxel-wise growth trajectories. Subjects were grouped by familial risk and clinical diagnosis at 2 years of age. Several regions, including the posterior cingulate gyrus, the cingulum, the fusiform gyrus, and the precentral gyrus, showed a significant effect for the interaction of group and age associated with ASD, either as an increased or a decreased growth rate of the cerebrum. In general, our results showed increased growth rate within white matter with decreased growth rate found mostly in grey matter. Overall, the regions showing increased growth rate were larger and more numerous than those with decreased growth rate. These results detail, at the voxel level, differences in brain growth trajectories in ASD during the first years of life, previously reported in terms of overall brain volume and surface area.

Identifiants

pubmed: 33421871
pii: S2213-1582(20)30388-0
doi: 10.1016/j.nicl.2020.102551
pmc: PMC7806791
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102551

Subventions

Organisme : NIEHS NIH HHS
ID : P30 ES010126
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD103525
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD103573
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD055741
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

A Cárdenas-de-la-Parra (A)

Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 0G4, Canada. Electronic address: alonso.cardenas-de-la-parra@mail.mcgill.ca.

J D Lewis (JD)

Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 0G4, Canada.

V S Fonov (VS)

Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 0G4, Canada.

K N Botteron (KN)

Mallinckrodt Institute of Radiology, Washington University, St. Louis, MO 63110, USA.

R C McKinstry (RC)

Mallinckrodt Institute of Radiology, Washington University, St. Louis, MO 63110, USA.

G Gerig (G)

Tandon School of Engineering, New York University, New York, New York 10003, USA.

J R Pruett (JR)

Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA.

S R Dager (SR)

Department of Radiology, University of Washington, Seattle, WA 98105, USA.

J T Elison (JT)

Institute of Child Development, University of Minnesota, Minneapolis, MN 55455, USA.

M A Styner (MA)

Department of Psychiatry, University of North Carolina, Chapel Hill, NC 27599, USA.

A C Evans (AC)

Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 0G4, Canada.

J Piven (J)

Department of Psychiatry, University of North Carolina, Chapel Hill, NC 27599, USA.

D L Collins (DL)

Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 0G4, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH